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Abstract
Background: The Twist1-family basic helix-loop-helix (bHLH) transcription factors including Twist1, Hand1 and Hand2, play
an essential role in heart development and are implicated in pathological heart remodeling. Previously, it was reported that
these bHLH transcription factors can be regulated by phosphorylation within the basic-helix I domain, which is involved in
developmental processes such as limb formation and trophoblast differentiation. However, how phosphorylation of Twist1
family functions in post-natal heart is elusive.
Principal Findings: Here, we generated transgenic mice with over-expression of Hand1 and Twist1 mutants (to mimic or to
abolish phosphorylation) in cardiomyocytes and found pathological cardiac remodeling leading to heart failure and sudden
death. Gene expression profile analysis revealed up-regulation of growth-promoting genes and down-regulation of
metabolic genes. It is well known that aberrant activation of Akt signaling causes pathological cardiac remodeling and
results in heart failure. The basic-helix I domain of Twist1 family members contain Akt substrate consensus motif and may
be downstream targets of Akt signaling. Using biochemical analysis, we demonstrated that Hand1 and Twist1 were
phosphorylated by Akt in the basic-helix I domain. Phosphorylation of Hand1 regulated its transcriptional activation of
luciferase reporter genes and DNA binding ability.
Conclusions: This study provides novel insights into the regulation of Twist1 family in cardiac remodeling and suggests that
the Twist1 family can be regulated by Akt signaling.
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Introduction
The Twist family of basic helix-loop-helix (bHLH) transcription
factors including Twist1/2, Hand1/2, Scleraxis and Paraxis, play
a variety of roles in both embryonic development and diseases
[1,2,3,4]. Among the Twist1 family members, Twist1 and Hand1
(also termed eHand, Hxt and Thing1) have been intensively
studied [2,5,6,7,8]. Biochemical studies have demonstrated that
Twist1 and Hand1/2 formed hetero-dimers or homo-dimer with
E12, E47 and between themselves to activate or suppress
transcription of downstream target genes through binding E-box
sequences such as the degenerate Thing1-box, CGTCTG, in the
cis-regulatory elements of target genes [1,6,9,10,11].
Protein phosphorylation plays an important role in regulating
the activity and function of Twist1 family members. Firulli and
colleagues first reported that PKA, PKC and PP2A (containing the
B56d regulatory subunit) could regulate phosphorylation of Hand1
and Hand2, which controled trophoblast cell line RCHO1
differentiation [12]. In a following study, Firulli’s group demon-
strated that phosphorylation regulates Twist1-Hand1 dimerization
and the results suggested that the partner choice of Twist1 family
protein dimerization is controlled by post-translational modifica-
tion, which is crucial for normal development [9]. Hand1 was also
reported to be phosphorylated by polo-like kinase Plk4 (Sak),
which regulated Hand1 cellular localization and determined cell
fate [13]. A recent study showed that phosphorylation of Twist1
affected its dimer affinity for a given partner and modulated the
DNA binding affinity, which might control limb development
[10].
Both Hand1 and Hand2 are essential for heart development as
either germ-line or cardiac-specific deletion of Hand1 and Hand2
in mice causes heart defects and mortality [5,8,14,15]. Hand1 was
also found to play a role in pathological heart remodeling in
human and rodent models [16,17]. Although phosphorylation of
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19251Twist1 family is important for embryonic development, its role in
post-natal heart function and remodeling remains elusive. For this
purpose, we generated transgenic mice with over-expression of
Hand1 and Twist1 wild-type and mutants (to mimic and to abolish
phosphorylation) in cardiomyocytes and found pathological heart
remodeling.
Akt signaling plays an important role in heart function, which
has been intensively investigated in the past decade
[18,19,20,21,22,23]. Aberrant activation of Akt signaling gives
rise to pathological cardiac remodeling including hypertrophy and
heart enlargement that leads to heart failure [24,25,26,27,28,29].
However, the downstream targets of Akt signaling involved in
heart remodeling are not well known [30].
The basic helix I domain of Twist1 family proteins contain a
well-conserved Akt substrate consensus motif suggesting that they
are putative Akt substrates. Through biochemical and cell
transfection assays, we demonstrated that both Twist1 and Hand1
could be phosphorylated by Akt, and phosphorylation regulated
their transcriptional activity and DNA binding affinity. This study
provides novel insights into the regulation of Twist1 family in
cardiac remodeling and suggests that the Twist1 family can be
regulated by Akt signaling.
Results
Mice over-expressing Hand1 and Twist1 mutants in
cardiomyocytes developed pathological cardiac
remodeling
The Twist1 family members of Hand1, Hand2, Twist1 and
Twist2 possess a well-conserved basic-helix I motif that contains
threonin and serine (Figure 1A). Therefore, phosphorylation of
Twist1 family may play a role in post-natal heart function. To
investigate this, we first generated transgenic (TG) mice expressing
Hand1-WT, -AA and -DD specifically in cardiomyocytes
(Figure 1B). Several lines of TG mice were obtained with distinct
expression levels of all three Hand1 genes (Figure 1C and Figure
S1C). Two mice lines expressing high-level Hand1-DD (designat-
ed DD80
high and DD68
high) displayed heart hypertrophy at 1
month that became more severe at 2 months (Figure 1D–F). The
majority of these mice died at 2–3 months and showed heart
hypertrophy and dilation (Figure 1D–F). Two lines with a
relatively low Hand1-DD expression (designated DD2
low and
DD63
low) developed heart hypertrophy at 2 months and the
majority of these mice died at 4–5 months (Figure 1E and 1F).
Echocardiography (Echo) tests on Hand1-DD mice indicated a
reduction in heart contractility and function at 8–10 weeks
(Table 1). These results showed a dose-dependent effect of Hand1-
DD. Two TG lines of Hand1-AA (including Hand1-AA13
high and
–AA26
low) displayed similar phenotypes: their hearts were
relatively small at 2 months, showing slight dilation and a
reduction in heart function (Figure 1D–F and Table 1). At 4–5
months, the Hand1-AA TG mice developed heart dilation and
enlargement. Hand1-AA and –DD TG mice showed increased
expression of Bnp, bMhc and Anf at 1 month indicating
pathological heart remodeling (Figure 1G). TG mice with over-
expression of Hand1-WT in heart did not display apparent
phenotype by 32 weeks, which was in consistence with a recent
report showing that Hand1-WT TG mice displayed mild
hypertrophy but were predisposed to cardiac arrhythmia [31].
Immunofluorescence microscopy and Masson’s staining on frozen
sections of control, Hand1-WT, -AA and -DD hearts displayed
cardiomyocyte size and fibrosis (Figure 1H). Both Hand1-AA and
-DD hearts displayed cardiomyocyte hypertrophy and fibrosis in
the left ventricular free wall at 2 months (Figure 1H and I). These
results indicate that aberrant phosphorylation (lower or higher) of
Hand1 caused pathological heart remodeling.
We collected hearts from these Hand1 TG mice and performed
microarray analysis to study gene expression profile. We found up-
regulation of several key growth-promoting genes such as Fgf1r,
Fgf12, Igf1, Igf1r and Cyclin D2 (Ccnd2) in Hand1-DD hearts
compared to Hand1-TG hearts (Table S1). RT-PCR result
confirmed increased Cyclin D1 and D2 in Hand1-DD hearts
(Figure S1A and B). Interestingly, genes involved in oxidative
phosphorylation and citrate cycle (TCA cycle) were found with
reduced expression in Hand1-DD hearts (Table S1). Cyclin D1
(Ccnd1) and cyclin D2 (Ccnd2) were also up-regulated in Hand1-AA
hearts and genes encoding collagen isoforms were high in both
Hand1-DD and –AA hearts consistent with fibrosis revealed by
histological study (Table S1 and Figure 1H).
We first detected Twist1 expression in mouse tissues by RT-
PCR and the result indicated that Twist1 was ubiquitously
expressed with varied amount (Figure 2A). In particular, we found
that Twist1 was expressed in heart ventricles (Figure 2A). Using a
similar strategy for generation of Hand1 TG mice, we obtained
Twist1-WT and -DD transgenic TG mice and found that while -
WT TG mice had comparable heart to control mice, Twist1-DD
TG mice displayed hypertrophy and some of them had atrial
septal defect (ASD) and ventricular septal defect (VSD) (Figure 2B–
D). Echo analysis indicated impaired heart function in Twist1-DD
mice compared to WT mice (Table 2 and Figure 2E and 2F).
Hand1 and Twist1 could be phosphorylated by Akt
in vitro and in vivo
In the past decade, the role of Akt signaling in post-natal heart
remodeling has been intensively investigated using Akt transgenic
mouse models [24,25,26,27,28,29]. These studies have demon-
strated that hyper-activation of Akt in cardiomyocytes caused
severe pathological cardiac remodeling leading to heart failure
[32]. Bioinformatic study using a computer program called
Scansite (http://scansite.mit.edu) has predicted a well-conserved
Akt substrate consensus motif in the basic-helix I domain of the
Twist1 family members (Figure 1A) [33]. Gene expression analysis
indicated increased expression levels of Igf1 and its receptor Igf1r
that activated Akt signaling pathway (Table 2). Therefore, the
Twist1 family could be regulated by Akt and might be involved in
heart remodeling.
An in vitro phosphorylation assay using GST-Hand1 fusion
protein demonstrated that mouse Hand1 could be phosphorylated
by Akt at two residues, T107 and S109 (Figure 3A). Mutation of
these two amino acids to alanine (A) in Hand1 abolished
phosphorylation by Akt (Figure 3A). The phosphorylation sites
were also confirmed by mass spectrometric analysis of GST-
Hand1 after Akt kinase assay, which identified phopho-Hand1
peptide (Figure 3B). Western blotting analysis using a phospho-
specific Hand1 antibody also showed Hand1 to be phosphorylated
at both T107 and S109 (Figure 3C).
The results so far all indicated that Akt phosphorylated Hand1
in vitro. We next studied Hand1 phosphorylation by Akt in cultured
mammalian cells by an in vivo biochemical assay. HA-Hand1
expressed in HEK293 cells alone or together with constitutively
active Akt was pulled down by immunoprecipitation (IP)
(Figure 3D). After SDS-PAGE and Coomassie blue staining,
Hand1 bands were excised and analyzed by mass spectrometry
(Figure 3D). No phospho-peptides were found in bands of Hand1
without co-transfection of Akt (Bands2–4 in Figure 3D), but
phospho-peptides with the sequence profile of RTpESINSA-
FAELR and RTESpINSAFAELR (with phosphorylation on T107
or S109) were identified in bands co-expressed with Akt (Bands 5–
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lation by Akt with phospho-specific antibody. In cells expressing
wild-type Hand1 and Hand1-DD (to mimic phosphorylation), a
phospho-band could be detected and the signal became stronger in
the presence of constitutively active Akt (m/p-Akt) while there was
no band with cells expressing Hand1-AA (to abolish phosphory-
lation) (Figure 3E). In addition, we studied Hand1 phosphorylation
by Akt with insulin stimulation. Cells were starved over-night by
serum withdrawal, and treated with insulin to activate Akt
(Figure 3F). Akt activation brought about Hand1 phosphorylation
which was blocked by LY-294002 (LY), an inhibitor of PI3K-Akt
signaling (Figure 3F). Similarly, Twist1 could also be phosphor-
ylated by Akt (Figure 3G and Figure S2). Furthermore, we also
tested Hand1/Twist1 phosphorylation by Akt in cultured
cardiomyocytes and the results were consistent with those
performed in HEK293 cells (Figure 3H). Collectively, these results
indicate that Hand1 and Twist1 are bona fide Akt substrates.
Akt suppressed Hand1 activation of reporter gene
transcription
Previous studies have shown that Hand1 forms heterodimers
with class A E-factors such as E12 and E47 to activate or suppress
transcription of downstream target genes via binding the ‘‘E-box’’
sequence (CANNTG) or the degenerate ‘‘D-box’’ sequence
(CGTCTG) [2,6,7,11]. Hand1 and Hand2 are close isoforms,
and their bHLH motives are nearly identical. It has been found
that the basic domain of Hand2 (RRR109-111) was crucial for
DNA binding and mutation of RRR109-111 to EDE abolished
Hand2 DNA binding and activation of luciferase reporter gene
transcription [34]. Akt1 phosphorylated Hand1 in the basic-helix
motif and might have similar function as Hand2 RRR109-
111EDD mutant on reporter gene expression. To investigate this,
we performed a luciferase reporter assay with an artificial Th1-
luciferase reporter plasmid containing six successive Th1(Hand1)
binding boxes (CGTCTG, D-box) followed by a basic a-cardiac
actin (a-CA) promoter and luciferase cDNA [6,11,13] (Figure 4A).
As shown in Figure 4B, E12 and Hand1 alone caused very weak
activation of luciferase expression whilst their combination
strongly activated the luciferase gene. Akt suppressed Hand1/
E12 activation of luciferase gene expression (Figure 4B, E).
Consistently, the phospho-mimic form of Hand1, Hand1-DD,
robustly suppressed luciferase gene activation (Figure 4B–D). The
non-phospho-Hand1, Hand1-AA, showed an equal or even higher
ability to activate luciferase expression that was dose-dependent
(Figure 4B–D).
Phosphorylation reduced Hand1 DNA binding ability
Using immunoprecipitation (IP) assay, we found that phosphor-
ylation of Hand1 did not alter its ability to bind E12 (Figure 5A).
Next, we studied Hand1/E12 DNA binding ability after
phosphorylation by gel shift and ChIP assay. As shown in
Figure 5B, Hand1-DD was abolished from DNA binding while
Hand1-AA displayed strong DNA binding ability. Furthermore,
ChIP assay also demonstrated that Hand1-DD had a much
weaker DNA binding ability than Hand1-WT and -AA
(Figure 5C). Consistently, Akt reduced Hand1 DNA binding
ability (Figure 5C). Similar to reporter gene regulation assay,
phospho-Hand1 showed the same effects on DNA binding as
Hand2RRR109-111EDE mutant [34].
Discussion
Our study has demonstrated that phosphorylation of Twist1
family played a critical role in heart remodeling in mouse models
and provided insights into the regulation of Twist1 family in heart
remodeling. This study indicated that the Twist1 family was
Figure 1. Generation and characterization of Hand1 TG mice. A. Alignment of the basic helix I domain among Twist1 family proteins in
different species. This motif (KERRRTES or KERRRTQS) is well conserved in the Hand/Twist proteins in fly, zebrafish, xenopus, mouse, rat and human.
Akt/PKB substrate consensus motif is K/R X K/R X X T/S (T and S are residues for phosphorylation) and can be identified in this motif. Letters in red (T
or S) indicate phosphorylation sites that are located in the basic-helix I domain. In both fly and zebrafish, there is only one Hand protein. B. Schematic
representation of the three constructs for generation of Hand1 TG mice. Solid blue tri-angles indicate two phosphorylation sites. Abbriviations: WT,
wild-type; AA, Hand1-T107A;S109A mutant; DD, Hand1-T107D;S109D mutant; TG, transgenic. C. Expression levels of Hand1 in TG hearts detected
with RT-PCR. Gapdh was used as control. DD
high indicated lines with high Hand1 expression while DD
low showed lines with low Hand1 expression. D.
Gross anatomy of Hand1 TG heart at 2 months. Note the hypertrophy and dilation phenotype of Hand1-DD
high hearts. E. Heart weight/body weight
ratio of Hand1 TG mice at two months. F. Survival curve of Hand1 TG mice. G. Expression of Bnp, b-Mhc and Anf in Hand1 TG hearts at 1 month.
Gapdh is for control. H. Histological analysis of left ventricular free wall of Hand1 TG hearts. To-Pro-3 stained nucleus; WGA staining displayed the size
of cardiomyocytes; Masson’s staining revealed fibrosis. Note the cardiomyocyte hypertrophy and fibrosis in Hand1-AA and –DD hearts. I.
Measurement of cardiomyocyte surface area of TG mice. *P,0.05 v.s. control.
doi:10.1371/journal.pone.0019251.g001
Table 1. Echocardiography of 8- to 10-week-old Hand1 TG mice.
Con(n=5) Hand1WT89
low TG (n=5) Hand1AA26
low TG (n=5) Hand1DD2
low TG (n=6)
FS% 33.0963.80 29.0764.72 20.7064.41* 17.4068.84*
EF% 62.6765.27 56.6167.29 41.4466.89 35.8967.44*
LVID; s (mm) 2.2760.37 2.4960.34 2.4360.29 3.0660.56*
LVPW; d (mm) 0.7360.06 0.8460.21 0.6860.07 0.7060.11
LVPW; s (mm) 1.1060.05 1.1460.17 0.8160.07* 0.8760.19*
LV Vol; d (ml) 47.19612.08 51.3569.38 46.17611.37 79.41620.11
LV Vol; s (ml) 18.1466.63 22.7567.20 21.2266.16 56.45610.34
*P,0.05 compared with control.
Abbreviations: EF, ejection fraction; FS, fractional shortening; LVID, left ventricular internal; LVPW, left ventricular posterior wall; LV Vol, left ventricular volume; d,
diastolic; s, systolic.
doi:10.1371/journal.pone.0019251.t001
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post-natal heart function. Previous studies have revealed an
essential role of Twist1 for embryonic development including
cardiac neural crest and valve morphogenesis [35,36,37]. Our
work suggests that phosphorylation of Twist1 family may also
regulate embryonic development. Work performed by Olson’s
group supports this hypothesis. They have shown that the basic
domain of Hand2 (RRR109-111) is crucial for DNA binding and
regulation of target gene expression. Mutation of RRR109-111 to
EDE abolished Hand2 DNA binding and activation of luciferase
reporter gene transcription [34]. In mice, RRR109-111EDE
mutation caused embryonic lethality at around E10.5 and right
ventricular hypoplasia [38]. Obviously, mutation of the basic
domain disrupts the consensus motif of Hand2 and abolishes
phosphorylation. The Twist1 family members of Hand1, Hand2,
Twist1 and Twist2 possess a well-conserved basic-helix I motif that
contains threonin and serine. Among them, Hand1, Hand2 and
Twist1 were previously reported to be phosphorylated by PKA,
PKC and Plk4 at the two residues of threonin and serine [9,12,13].
Another study showed that Hand2 could be phosphorylated at the
same residues by Akt [39]. Phosphorylation of these Twist1 family
members regulates developmental process and cell fate determi-
nation such as limb formation and trophoblast differentiation
[9,10,12,13]. Studies of mutant mice have shown that Hand1,
Hand2 and Twist1 play a critical role in heart development
[5,8,14,15]. Hand1 and Hand2 were found involved in the
development of cardiomyopathy in rodents and human [16,17]. In
the future, generation of inducible/conditional knock-in mutation
Figure 2. Detection of Twist1 expression, generation and characterization of Twist1 TG mice. A. RT-PCR detection of Twist1 expression in
mouse tissues. Note that Twist1 is expressed in heart ventricles. B. Schematic representation of the two constructs for generation of Hand1 TG mice.
WT, Twist1 wild-type; DD, Twist1 T125D; S127D mutant. C. Detection of Twist1 expression in the heart of TG mice by western analysis using HA
antibody. D. Histological study of hearts from Twist1 TG mice (20 days). Note that Twist1-DD mice show heart hypertrophy and atrial septal defect
(ASD, indicated by arrow) while WT mice have comparable heart to control (data not shown). E and F. Heart’s function analysis by echocardiography.
doi:10.1371/journal.pone.0019251.g002
Table 2. Echocardiography of 20-day Twist1 TG mice.
WT (n=6) Twist1DD (n=7)
IVS; d (mm) 0.5960.02 0.7260.03
LVID; d (mm) 2.6860.04 2.7260.07
LVPW; d (mm) 0.6160.01 0.7160.05
IVS; s (mm) 0.6960.03 0.7260.03
LVID; s (mm) 1.6160.03 2.2460.07*
LVPW; s (mm) 0.8760.02 0.7660.05
LV Vol; d (ı `l) 26.8460.91 28.5761.50
LV Vol; s (ı `l) 7.4960.42 18.2161.07**
EF % 72.0261.25 38.4362.11**
FS % 39.9661.04 18.2061.20**
LV Mass (mg) 41.3160.72 54.9863.46
LVMass Corrected (mg) 33.0560.57 43.9862.77
*P,0.05 and
**P,0.005.
Abbreviations: IVS, interventricular septum; LVID, left ventricular internal; LVPW,
left ventricular posterior wall; LV Vol, left ventricular volume; EF, ejection
fraction; FS, fractional shortening; d, diastolic; s, systolic.
doi:10.1371/journal.pone.0019251.t002
Twist1 Family in Pathological Heart Remodeling
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19251Twist1 Family in Pathological Heart Remodeling
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e19251mice will make it possible to explore the role of Twist1 family
phosphorylation in post-natal heart function.
In this study, we found that phosphorylation of Hand1
suppressed its transcriptional activity. Previously, Firulli and
colleagues performed comprehensive study of Twist1-AA and
Twist1-DD mutation on transcriptional activity regulation and
their results indicated that both reduced gene transcription of
luciferase reporters [10]. In human patients with cardiomyopathy
as well as rodent models of cardiac hypertrophy, Hand1 gene
expression levels were found reduced suggesting a correlation
between Hand1 levels and heart remodeling [16,17]. Combined
with our transgenic mouse models, these studies suggest that
Twist1 and Hand1 may play a growth-inhibitory role in post-natal
heart and phosphorylation may release their inhibitory effects
leading to hypertrophy. Data obtained from microarray analysis
supports this hypothesis because we found increased expression
levels of growth-promoting genes including Fgf1r, Fgf12, Igf1, Igf1r,
Cyclin D2 in Hand1-DD heart. Interestingly, the genes involved in
oxidative phosphorylation and TCA (citrate) cycle were found
with reduced levels in Hand1-DD heart suggesting that decreased
metabolism may result in heart failure [40].
Previously, it was reported that AktphosphorylatedHand2 in vitro
and phosphorylation negativelyregulatedHand2 DNAbindingand
activation of luciferase reporter gene expression [39]. Our results
are consistent with this study. However, how Hand2 phosporylation
functions in heart development and remodeling remains unknown.
In the future, it will be necessary to study this Akt-Hand2
relationship in mice because of distinct expression pattern of Hand1
and Hand2 in left and right ventricles [2].
The role of Akt in pathological heart remodeling has been
intensively investigated by studying transgenic mice with Akt over-
expression in cardiomyocytes [18,20,22,23,24,25,26,27,28,29,41,
42,43,44]. These studies have demonstrated that aberrant activa-
tion of Akt in cadiomyocytes gave rise to pathological hypertrophy.
On the other hand, reduction of Akt activity in cardiomyocytes
resulting from deletion of its upstream kinase, PDK1, also caused
pathological cardiac remodeling (dilated cardiomyopathy and heart
enlargement) [45,46]. Using aMhc-Cre, we deleted PDK1 in
cardiomyocytes and obtained similar results (data not shown). Gene
expression study indicated increased expression levels of Igf1 and its
receptor in Hand1-DD heart, which suggested that IGF1-PDK1-
Akt-Hand1 positive feedback loop might contribute greatly to the
phenotype. This needs to be tested in the future. Taken together,
these studies suggest that the Twist1 family might be the key
downstream players in heart hypertrophy/dilation induced by
abnormal Akt signaling (enhancement or reduction).
Intriguingly, Hand1S109G mutation in the phosphorylation
motif has been identified in human VSD heart sample pinpointing
the role of phosphorylation regulation of Hand1 in heart
development [47]. In the future, it will be worthwhile to search
for Hand1 mutations in patients with pathological heart
remodeling, such as hypertrophic and dilated cardiomyopathy
(HCM and DCM).
In summary, we have identified a novel regulatory mechanism
of Twist1 family involved in cardiac remodeling. Our work
suggests that modulation of Akt activity (enhancement or
reduction) by agonists or inhibitors may have therapeutic
application on pathological cardiac remodeling. Meanwhile, this
study puts caution on pharmacological development of inhibitors
to suppress PI3K-Akt signaling against tumor growth in that
reduction of Akt signaling may have severe cardiac toxicity.
Materials and Methods
Chemicals and antibodies
LY-294002 (cat# 440202) was from Calbiochem and insulin
from Sigma. The following antibodies were from Cell Signaling
Technology (CST): total Akt (9272), pSer473 phospho-Akt
antibody (9271), Twist1 (4119) and Tubulin (2148). Pan-actin
antibody (MS-1295-P0) and HRP-linked secondary antibodies
(Prod #31460 and Prod #31430) were from Thermos Scientific.
The HA (FMI 42F13) and Myc (9E10) antibodies were from a
hybridoma cell culture supernatant maintained in the authors’
laboratory.
Plasmids construction
Mouse Hand1 cDNA was cloned from E14.5 placenta by RT-
PCR and the two primer sequences were: forward, BamHI GGA
TCC ACC (HA tag) ATG GCT TAC CCA TAC GAT GTT CCA GAT
TAC GCT TCG (Hand1-59) AAC CTC GTG GGC AGC TAC
GCA; reverse, BamHI GGA TCC (Hand1-39) TCA CTG GTT
TAG CTC CAG CGC. The PCR product is 699 bp encoding a
protein of 227 amino acids (including12 amino acids of the HA
tag). The PCR product was further cloned into pGEMT-easy to
generate pGEMT-easy-HA-mHand1 and verified by sequencing.
For mammalian expression vector construction, pGEMT-easy-
HA- mHand1 was digested with BamHI and the fragment (699 bp)
released was subcloned into pCMV5 at a BamHI site, resulting in
pCMV5-HA-mHand1; the orientation was verified by HindIII
digest. To construct the E. coli expression vector pGEX2T-HA-
mHand1, the 699-bp fragment above was subcloned into
pGEX2T at a BamHI site and the orientation verified by HindIII
Figure 3. Hand1 and Twist1 could be phosphorylated by Akt in vitro and in vivo.A . Autoradiography of an in vitro phosphorylation assay
showing that Akt phosphorylates Hand1 at both Thr107 (T107) and Ser109 (S109). DPH-Akt is an Akt mutant without the PH domain and is
constitutively active. T107A and S109A are Thr107 and Ser109 mutations to alanine that block phosphorylation. B. SDS-PAGE gel showing separation
of GST-Hand1 and DPH-Akt after an in vitro phosphorylation assay. The GST-Hand1 band (framed in red) was excised from SDS-PAGE gel and applied
to Mass spectrometric analysis. The result confirmed Hand1 phosphorylation by Akt. C. Western blot using phospho-Hand1-specific antibody to
detect Hand1 phosphorylation by Akt. In the GST-HA-HandT107A protein, S109 could be phosphorylated by Akt and detected with the phospho-
specific antibody. The similar effects were observed in GST-HA-Hand1S109A protein. D. Mass spectrometric analysis of Hand1 phosphorylation by Akt
in transfected HEK293 cells. HA-Hand1 proteins were pulled down by immunoprecipitation (IP) and were separated with SDS-PAGE gel. The bands
containing Hand1 (2–8) were excised for Mass spectrometric analysis leading to identification of peptides with T107 or S109 phosphorylation in
bands 5–8 (from cells transfected with HA-Hand1 together with constitutively active Akt–m/p-Akt). No phosphor-peptide was detected in bands 2–4
in the absence of Akt. IgH and Ig L mean immunoglobulin heavy and light chain. E. Western blotting analysis using phospho-Hand1 antibody to
detect Hand1 phosphorylation in transfected cells. Akt augmented Hand1 phosphorylation. The antibody also detected Hand1-DD protein which
mimics Hand1 phosphorylation but to a lesser extent while it did not recognize Hand1T107AS109A. F. Study of Hand1 phosphorylation in HEK293
cells with insulin to activate Akt. After transfection, cells were starved over-night by withdrawal of serum from medium and insulin was added to the
cells for 15 minutes resulting in Akt phosphorylation and activation. Avtivation of Akt, in turn, phosphorylated Hand1. This is blocked by LY204002
(LY), a PI3K inhibitor. P-Akt represents Akt phosphorylation and activation. G. Study of Twist1 phosphorylation in HEK293 cells as for Hand1. H. Test of
Hand1/Twist1 phosphorylation by Akt in mouse cardiomyocytes.
doi:10.1371/journal.pone.0019251.g003
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mutants were obtained with a site-specific mutagenesis kit
(Invitrogen) and the sequences of the two pairs of oligos were:
for T107AS109A, 59-G AAG GAG AGG AGA CGC GCA GAG
GCC ATT AAC AGC GCG TTC-39 and 59-GAA CGC GCT
GTT AAT GGC CTC TGC GCG TCT CCT CTC CTT C-39;
for T107DS109D, 59-G AAG GAG AGG AGA CGC GAC GAG
GAC ATT AAC AGC GCG TTC-39 and 59-GAA CGC GCT
GTT AAT GTC CTC GTC GCG TCT CCT CTC CTT C-39
(sequences for mutated amino acids are underlined). Single amino
acid mutants (T107A or S109A) were acquired by a similar
strategy. Mouse Twist1 was amplified by PCR using pcDNA3-HA-
Twist1 (a gift from Dr. Gerard Karsenty at the Baylor Medical
College) as template and the two primers are: (forward) BamHI
GGA TCC ACC (HA tag) ATG GCT TAC CCA TAC GAT GTT
CCA GAT TAC GCT TCG (Twist1-59) ATG CAG GAC GTG
TCC AGC TCG; (reverse) EcoRI GAA TTC (Twist1-39) CTA
GTG GGA CGC GGA CAT. The amplified fragment was ligated
into pCMV5 for mammalian cell transfection (pCMV5-HA-
Twist1). The mTwist1T125AS127A and mTwist1T125DS127D
mutants were obtained with a site-specific mutagenesis kit
(Invitrogen) and the sequences of the two pairs of oligos were:
for T125AS127A, 59-CGG GAG CGC CAG CGC GCG CAG
GCG CTG AAC GAG GCG TTC GCC GCC-39 and 59-GGC
GGC GAA CGC CTC GTT CAG CGC CTG CGC GCG CTG
GCG CTC CCG-39; for T125DS127D, 59-CGG GAG CGC
CAG CGC GAC CAG GAC CTG AAC GAG GCG TTC GCC
GCC-39 and 59-GGC GGC GAA CGC CTC GTT CAG GTC
CTG GTC GCG CTG GCG CTC CCG-39 (sequences for
mutated amino acids are underlined). Single amino acid mutants
Figure 4. Akt phosphorylation suppressed Hand1 activation of a luciferase reporter gene. A. Structure of Th1-luciferase reporter. Th1
represents the Th1-box sequence (CGTCTG, D-box) that is bound by Hand1. aCA is a-cardiac actin. Six successive Th1-boxes are located upstream of
aCA promoter. B. Hand1-WT and –AA (T107AS109A) activate the luciferase reporter gene, whilst –DD (T107DS109D) represses this activation. Akt also
inhibits Hand1-WT activation of the reporter gene. C. Hand1-DD suppresses reporter gene activation. D. Effects of three Hand1 proteins on reporter
gene expression. E. Akt action on Hand1 regulation of reporter gene expression. These assays were performed with lysates from HEK293 cells
transfected with corresponding plasmids. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0019251.g004
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mutagenesis, the sequences were verified by sequencing. pCI-E12
was obtained from Martin Knoefler (University of Vienna,
Austria), the reporter plasmid of 66Thing1-Luciferase from Paul
Riley (University College London), and the ANF-luciferase
reporter plasmids from Mona Nemer (University of Ottawa,
Canada) and Anning Lin (University of Chicago), respectively.
pCMV5-Myc-E12 was generated by PCR using pCI-E12 as a
template and the product was cloned into pCMV5 at EcoRI and
BamHI sites. The two primer sequence were: forward, EcoRI GAA
TTC ACC (Myc tag) ATG GAA CAA AAA CTT ATT TCT GAA GAA
GAT CTG (E12-59) GCG CCT GTG GGC ACA GAC; reverse,
BamHI GGA TCC (E12-39) TCA CAT GTG CCC GGC GGG.
pCMV5-myc-mTbx5 was cloned by PCR using the plasmid
Tbx5-pcDNA3 from Katherine Yutzey (Cincinnati Children’s
Hospital Medical Center) as template.
GST-HA-mHand1 fusion protein purification and
generation of antibodies
GST-HA-mHand1 wild type, T107A, S109A, and
T107AS109A fusion proteins were produced in E. coli with
pGEX2T vectors; 0.1 mM IPTG was used to induce fusion
protein production, the majority of which was in the form of
inclusion bodies. To purify the fusion protein, the cell pellet was
lysed by sonication in PBS containing 2 mM EDTA, 10 mM
DTT, 0.5 mM PMSF and 1 mM benzamidine, followed by
centrifugation. This step was repeated 2–3 times to wash the
inclusion body. Purified inclusion bodies were sonicated again in
PBS with 10 mM DTT, 0.1% SDS, and 10% glycerol (which
helped dissolve the protein). The supernatant was collected and
dialyzed overnight in PBS at 4uC. To generate a Hand1 antibody,
a peptide with the sequence IPNVPADTKLSKIKTLRLATSYIA
was used to immunize two rabbits after conjugation with
exogenous protein (Nanjing Chuanbo Biotech. Co., Ltd.). The
anti-sera were affinity purified and tested on cell transfections or
mouse heart tissues by western blotting. A similar procedure was
used for the generation and purification of Hand1T107pS109p
phospho-specific antibody using the peptide sequence KKERR
RTpESpINSAFA (Nanjing Chuanbo Biotech. Co., Ltd.).
Cell culture, transfection, treatment and luciferase
reporter assay
HEK293 cells were maintained in DMEM plus 10% fetal
bovine serum (Gibco and Hyclone) and transfected using either
FuGene HD (Roche) or GenEscort (Nanjing Wisegen Biotech.
Co., Ltd) and plasmid amounts of 10 mg per 10-cm dish or 2 mg
per well in 6-well plates. For treatment, the cells were first serum-
starved for 20 h at 1 day after transfection and then treated with
insulin (0.1 mM) for 15 min or LY294002 (20 mM) for 2 h prior
to insulin treatment. For the luciferase reporter assay, HEK293
cells were plated into 12-well plates and transfected with 100 ng
66Thing1 luc. plasmid or ANF-luc. plasmid, 10 ng pRL-TK-ren.,
100 ng pCI-E12, 100 ng pCMV5-Hand1 wild type or mutants
and 100 ng pCMV5-m/p-Akt. In other experiments, different
amounts of plasmids were used, as indicated. The total amount of
DNA in each treatment was normalized with pCMV5 empty
plasmid. Each transfection was performed in duplicate. Cells were
collected 48 h after transfection for the dual-luciferase assay using
the Promega assay system (Glomax). Each assay was repeated at
least three times.
Neonatal mouse cardiomyocyte culture and lenti-viral
infection
Cardiomyocytes were isolated as previously described [48].
Briefly, hearts were dissected from newborn mice and atria were
Figure 5. Hand1 phosphorylation did not affect heterodimer formation with E12 but abolishes DNA binding. A. HA-Hand1-WT, -AA
and -DD plasmids were co-transfected with Myc-E12. HA-Hand1 was pulled down by HA-IP and blotted with an antibody against Myc. Myc-E12 was
found to bind to all three HA-Hand1 proteins. B. Gel shift assay. Hand1-AA showed strong DNA binding while phosphorylation (Hand1-DD) abolished
the DNA binding (indicated by arrows). Co represents competition oligo. C. ChIP assay. Hand1 wild-type and mutants was expressed with or without
Akt in HEK293 cells. Using nuclear extracts from these cells, ChIP assay was performed and the results showed that Hand1-AA had stronger DNA
binding than Hand1-DD. Akt also reduced Hand1 DNA binding ability. Abbreviations: Neg con, negative control; Pos con, positive control.
doi:10.1371/journal.pone.0019251.g005
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incubated in collagenase (type 2, Sigma) at 37uC for 10 minutes.
Subsequently, supernatants were filtered and cells in supernatants
were collected by centrifugation. These cells were cultured in
DMEM plus 10% fetal bovine serum (Hyclone). Most of the cells
started to beat after 24 hours of culture. For lenti-viral
construction, a system including lentiviral vector FuGW(ubiquitin
promotor), envolope plasmid pMD2G and packaging plasmid
pSPAX2 was used (a gift from Dr. Ying Wan at Department of
Laboratory Animal Science, Third Military Medical University,
China). Coding sequences of Hand1, Twist1 and Akt1 were
obtained from pCMV5-HA-Hand1, pCMV5-HA-Twist1 and
pCMV5-Flag-Akt1 and ligated into FuGW at the BamH1 and
EcoR1 sites. Lentivirus was prepared as described in Tronolab
(http://tronolab.epfl.ch). Briefly, about 4610
6 293FT cells were
plated in a 10 cm cell culture dish. At 80–90% confluency, the
cells were co-transfected with 5 mg of envelop plasmid, 15 mgo f
packaging plasmid and 20 mg of lentiviral vector using calcium
phosphate precipitation. After 9 h, the medium was removed and
10 ml of fresh DMEM plus10% FBS (Hyclone) was added to each
dish. 48 h later, supernatant was collected and 1 ml of supernatant
was added in to the neonatal mouse cardiomyocytes cultured in 6-
well plate for cell infection. 24 h later, the medium was removed
and 3 ml of fresh DMEM plus10% FBS (Hyclone) was added to
each well. 48 h later about 80% of cells were GFP positive and
cells were collected for analysis.
In vitro and in vivo phosphorylation assay
Phosphorylation of GST-Hand1 and mutants were carried out
at 30uC for 30 minutes in a volume of 50 ul of kinase assay buffer
containing GST-Hand1 or mutants, hot-ATP and active Akt.
The samples were subjected to SDS-PAGE followed by
autoradiography. For mass spectrometric assay, bands (GST-
Hand1 or HA-Hand1 from immunoprecipitation) were excised
from SDS-PAGE gel for in-gel tryptic digestion and the peptides
were separated by capillary liquid chromatography tandem mass
spectrometry (LC-MSMS) using a Magic C18 100 mm610 cm
HPLC column (Swiss BioAnalytics, Switzerland) on a 1100
Nano-HPLC system (Agilent, Palo Alto, CA) connected on line to
a 4000 Q Trap (MDS Sciex, Concord, Ontario, Canada) [49].
MASCOT searching SwissProt_57.6 was used to identify the
phosphopeptides. Individual spectra were further evaluated
manually.
Western blotting analysis and immunoprecipitation
Cells and hearts were collected and snap-frozen in liquid
nitrogen until use. Cell/tissue lysates were prepared in lysis buffer
(20 mM Tris, 150 mM NaCl, 10% glycerol, 20 mM glycerophos-
phate, 1% NP40, 5 mM EDTA, 0.5 mM EGTA, 1 mM Na3VO4,
0.5 mM PMSF, 1 mM benzamidine, 1 mM DTT, 50 mM NaF,
4 mM leupeptin, at pH 8.0). Samples were resolved by 10% SDS-
PAGE and transferred to PVDF membranes (Millipore). Mem-
branes were blocked with 5% non-fat milk in TBST (50 mM Tris,
150 mM NaCl, 0.5 mM Tween-20, pH 7.5) and incubated with
primary antibodies overnight at 4uC. Immunoprecipitation was
performed using protein A sepharose CL-4B beads (Amersham-
Pharmacia).
Gel shift assay
Nuclear extracts from HEK293 cells overexpressing Hand1-AA
and Hand1-DD were prepared using a nuclear extract kit (Active
motif) according to manufacturer’s instructions. Oligonucleotides
containing a consensus Hand1 binding site (Th1 D-box) that
wasdescribed previously were synthesized as follows: (Sense)
59-ATTGGCGTCTGGCATTGCATTGGCGTCTGGCATT-
GCATTGGCGTCTGGCATT-39; (Anti-sense) 59–GATCTA-
ATGCCAGACGCCAATGCAATGCCAGACGCCAATGCA-
ATGCCAGACGCCAATGAGCT-39 (D-box sequences were
underlined) [11]. The two oligonucleotides were annealed and
used as probe. Gel shift assays were performed using a gel shift
assay kit (Promega) according to manufacturer’s instructions.
ChIP assay
Cell lysates and nuclear extracts were prepared from HEK293
cells over expressing HA-Hand1-WT, HA-Hand1-AA, HA-
Hand1-DD and HA-m/p-AKT plus HA-Hand1-WT, respec-
tively. The 66Thing1 DNA fragment containing six successive
Hand1 D-box (CGTCTG) sequences was prepared by KpnI
and SacI digestion from 66 Thing1 luc vector. The nuclear
extracts and 66 thing1 DNA fragment were incubated in
56binding buffer (20% glycerol, 5 mM MgCl2, 2.5 mM EDTA,
2.5 mM DTT, 250 mM NaCl, 50 mM Tris-HCl (pH 7.5),
0.25 mg/ml poly(dI-dC)Npoly(dI-dC)) for 30 minutes at room
temperature. Immuoprecipitation was performed using HA
antibody (1:100) according to the manufacturer’s instructions of
Upstate ChiP assay kit. DNA was recovered by phenol/
chloroform extraction and ethanol precipitation. The following
PCR primers against 66Thing1 fragment were used as follows:
59-CATTGGCGTCTGGCATTATTG-39 and 59-AGCTCAA-
TGCCAGACGCCAAT-39.
Mice
Mice were housed in accordance with the regulations on mouse
welfare and ethics of Nanjing University in groups with 12-h dark-
light cycles and free access to food and water. The experimental
animal facility has been accredited by AAALAC (Association for
Assessment and Accreditation of Laboratory Animal Care
International) and the IACUC (Institutional Animal Care and
Use Committee) of Model Animal Research Center of Nanjing
University approved all animal protocols used in this study. Hand1
and Twist1 transgenic mice were generated through pro-nuclear
injection of plasmid DNA. HA-Hand1, HA-Twist1 wild-type and
mutants were ligated into alpha-MyHC clone 26 (a gift from Dr.
Jeffrey Robbins at the Cincinnati Children’s Hospital Medical
Center) at SalI site and the plasmids were linearized with NotI [50].
Founders were genotyped by PCR and expression levels were
examined with western blot analysis. Progenies of founders were
backcrossed to C57/B6 genetic background. Primers for genotyp-
ing of Hand1 TG mice are: forward 59-GCTGCCTATG-
GTCCCGATGCCA-39 and reverse (hGH poly A in the vector)
59-GCACTGGGGAGGGGTCAC-39. The PCR product was
456 bp. Primers for genotyping of Twist1 TG mice are: forward:
59-GCGGGTCATGGCTAACG-39 and reverse: 59-GCACTG-
GGGAGGGGTCAC-39. The size of PCR product is 400 bp.
Echocardiography (Echo)
Echo was performed with Vevo 660 UBM (VisualSonics,
Toronto, ON, Canada) that possesses a single-element mechan-
ical transducer with a center frequency of 30 MHz and a frame
rate of 30 Hz. The spatial resolution of B-mode imaging was
,115 um (lateral) by ,55 um (axial). Mice were anesthetized
with Avertin that was prepared as a 1.2% solution and
administrated to mice at a dose of 0.2 ml/10 grams body weight
(approximately 240 mg/kg body weight). Body temperature of
mice was monitored by rectal thermometer and was maintained
between 36 and 38uC. The heart rate was maintained between
350–450 beats/min.
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The hematoxylin-eosin (HE) and immunohistochemical (IHC)
protocols were as described previously [51,52]. Briefly, hearts were
washed with cold PBS and fixed in formalin overnight at 4uC. The
samples were processed successively by (a) a 30-min wash in PBS
at 4uC, (b) a 1-h incubation in 70%, 80%, 95%, and 361h
incubation in 100% ethanol at room temperature (RT), (c)
3620 min incubation in xylene at RT, (d) a 1-h incubation in
paraffin/xylene (1:1) at 65uC, (e) 361 h incubation in fresh
paraffin at 65uC. The processed samples were then embedded in
paraffin and sectioned (7 mm thick) and the sections HE stained
following the standard protocol. For IHC, frozen-sections were
incubated at 4uC overnight with antibodies for HA and To-Pro 3
iodine (642/661, Molecular Probes). Images were processed with
an Olympus confocal microscope system.
Microarray analysis
Three hearts were dissected from each group of control, Hand1-
WT, -DD and AA mice. Total RNA was isolated from each three
hearts and was pooled together. In total, four RNA samples were
applied for microarray analysis (Affymetrix Mouse 430 2.0 Array,
Shanghai Biochip Co. Ltd.). The data was analyzed by use of
Molecular Annotation System (Beijing CapitalBio Corporation).
Masson’s trichrome staining
Myocardial fibrosis in myocardial infarct mice were detected by
masson’s trichrome staining. Hearts were cross-sectioned in 6 mm
thick and then stained accroding to the protocol (http://www.
ihcworld.com/_protocols/special_stains/masson_trichrome.htm).
Statistics
Data were presented as mean6SD values. For comparisons
between two groups, statistical significance was determined using
the unpaired two-tailed t-test. A value of P,0.05(*) was considered
statistically significant and P,0.01(**) statistically very significant.
Supporting Information
Figure S1 A. Analysis of gene expression in Hand1 TG
hearts by RT-PCR. Three individual hearts for each group
were analyzed. * indicates up-regulation in –AA and –DD hearts
compared to control and –WT. B. Quantitation of A, * represents
P,0.05. C. RT-PCR analysis of total Hand1 expression in
multiple tissues of TG mice.
(TIF)
Figure S2 Study of Twist1 phosphorylation by Akt in
U2OS cells.
(TIF)
Table S1 Microarray analysis of Hand1 TG hearts
(DOC)
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